Dean Y. Li - 01 Apr 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Apr 2024
Transactions value $
$0
Form type
4
Filing time
03 Apr 2024, 17:43:25 UTC
Previous filing
12 Feb 2024
Next filing
02 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1,267 +2.19% $0.000000 59,089 01 Apr 2024 Direct F1
holding RXRX Class A Common Stock 1,422,048 01 Apr 2024 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 1,269,796 01 Apr 2024 By Dean Y. Li GRAT F2
holding RXRX Class A Common Stock 421,000 01 Apr 2024 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
F2 The reporting person is the sole trustee for this GRAT. Shares transferred by the reporting person to the GRAT on March 5, 2024.